Archives of physical medicine and rehabilitation · 2024
Effect of Virtual Reality-Based Cardiac Rehabilitation on Mental Health and Cardiopulmonary Function of Individuals With Cardiovascular Disease: A Systematic Review and Meta-analysis.
СтатьяМетаанализСистематический обзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Saikun, Jiang Junjie, Zhang Changyue, Lv Mengjiao, Xu Haiyan, Meng Hongli, Guo Lirong
Аннотация
OBJECTIVE: To investigate the effect of virtual reality (VR)-based cardiac rehabilitation (CR) on the mental health and cardiorespiratory function of patients with cardiovascular disease (CVD).
DATA SOURCES: The search strategy was conducted in 5 databases (PubMed, Scopus, Web of Science, Embase, and Cochrane Library databases) from inception to July 2024.
STUDY SELECTION: Randomized controlled trials comparing the effectiveness of standard CR and VR-based CR for patients with CVD were independently selected by multiple reviewers.
DATA EXTRACTION: Data were extracted independently by 2 authors. In case of disagreement, a third author was consulted for resolution.
DATA SYNTHESIS: Thirteen studies involving 955 patients with CVD were included in the meta-analysis. The results showed that VR-based CR reduced anxiety levels (standard mean difference [SMD]=-0.28, 95% [confidence interval] CI [-0.51 to -0.05], P=.020]) and depression symptoms (SMD=-0.28, 95% CI [-0.53 to -0.02], P=.030]) in patients with CVD compared with standard CR. However, no significant difference was observed in peak oxygen consumption (SMD=0.01, 95% CI [-0.14 to 0.16], P=.920]) between standard CR and VR-based CR.
CONCLUSIONS: VR-based CR significantly improved anxiety and depression symptoms in patients with CVD compared with standard CR. However, there was no significant difference between standard CR and VR-based CR in improving cardiorespiratory function in patients with CVD.
DATA SOURCES: The search strategy was conducted in 5 databases (PubMed, Scopus, Web of Science, Embase, and Cochrane Library databases) from inception to July 2024.
STUDY SELECTION: Randomized controlled trials comparing the effectiveness of standard CR and VR-based CR for patients with CVD were independently selected by multiple reviewers.
DATA EXTRACTION: Data were extracted independently by 2 authors. In case of disagreement, a third author was consulted for resolution.
DATA SYNTHESIS: Thirteen studies involving 955 patients with CVD were included in the meta-analysis. The results showed that VR-based CR reduced anxiety levels (standard mean difference [SMD]=-0.28, 95% [confidence interval] CI [-0.51 to -0.05], P=.020]) and depression symptoms (SMD=-0.28, 95% CI [-0.53 to -0.02], P=.030]) in patients with CVD compared with standard CR. However, no significant difference was observed in peak oxygen consumption (SMD=0.01, 95% CI [-0.14 to 0.16], P=.920]) between standard CR and VR-based CR.
CONCLUSIONS: VR-based CR significantly improved anxiety and depression symptoms in patients with CVD compared with standard CR. However, there was no significant difference between standard CR and VR-based CR in improving cardiorespiratory function in patients with CVD.